Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer

Koichiro Abe; Shingo Baba; Koichiro Kaneko; Takuro Isoda; Hidetake Yabuuchi; Masayuki Sasaki; Shuji Sakai; Ichiro Yoshino; Hiroshi Honda

doi:10.1016/j.clinimag.2008.06.032

Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer

Koichiro Abe, Shingo Baba, Koichiro Kaneko, Takuro Isoda, Hidetake Yabuuchi, Masayuki Sasaki, Shuji Sakai, Ichiro Yoshino, Hiroshi Honda

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Purpose: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC. Methods: Forty-four patients (26 males, 18 females) were analyzed. Results: Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073). Conclusion: FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.

Original language	English
Pages (from-to)	90-95
Number of pages	6
Journal	Clinical Imaging
Volume	33
Issue number	2
DOIs	https://doi.org/10.1016/j.clinimag.2008.06.032
Publication status	Published - Mar 2009

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clinimag.2008.06.032

Cite this

@article{34fc6c01efdb4bffada6411650d78fa7,

title = "Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer",

abstract = "Purpose: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC. Methods: Forty-four patients (26 males, 18 females) were analyzed. Results: Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073). Conclusion: FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.",

author = "Koichiro Abe and Shingo Baba and Koichiro Kaneko and Takuro Isoda and Hidetake Yabuuchi and Masayuki Sasaki and Shuji Sakai and Ichiro Yoshino and Hiroshi Honda",

year = "2009",

month = mar,

doi = "10.1016/j.clinimag.2008.06.032",

language = "English",

volume = "33",

pages = "90--95",

journal = "Clinical Imaging",

issn = "0899-7071",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer

AU - Abe, Koichiro

AU - Baba, Shingo

AU - Kaneko, Koichiro

AU - Isoda, Takuro

AU - Yabuuchi, Hidetake

AU - Sasaki, Masayuki

AU - Sakai, Shuji

AU - Yoshino, Ichiro

AU - Honda, Hiroshi

PY - 2009/3

Y1 - 2009/3

N2 - Purpose: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC. Methods: Forty-four patients (26 males, 18 females) were analyzed. Results: Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073). Conclusion: FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.

AB - Purpose: The aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC. Methods: Forty-four patients (26 males, 18 females) were analyzed. Results: Accurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073). Conclusion: FDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=60349087400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60349087400&partnerID=8YFLogxK

U2 - 10.1016/j.clinimag.2008.06.032

DO - 10.1016/j.clinimag.2008.06.032

M3 - Article

C2 - 19237050

AN - SCOPUS:60349087400

SN - 0899-7071

VL - 33

SP - 90

EP - 95

JO - Clinical Imaging

JF - Clinical Imaging

IS - 2

ER -

Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this